Arrhythmias/Electrophysiology
M-A | Colchicine for prevention of post-operative atrial fibrillation
27 Jan, 2023 | 12:03h | UTC
RCT | Small study suggests hybrid ablation is more effective than repeated catheter ablation in persistent atrial fibrillation
23 Jan, 2023 | 13:23h | UTC
EASY-WPW: a novel ECG-algorithm for localization of manifest accessory pathways in children and adults
20 Jan, 2023 | 14:26h | UTC
Commentary on Twitter
Make it #EASY: read more about a novel #ECG-based algo for accessory pathway localization with superior discriminatory power compared to existing tools in the latest #Europace issue https://t.co/9b47kzwe5i@melhamriti @Phiso_de @ABollmannMD @GerdHindricks #EHRA_ESC #EPeeps pic.twitter.com/qyyQZD0F6e
— European Society of Cardiology Journals (@ESC_Journals) December 16, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ license
RCT | In patients with AF undergoing ablation, the addition of posterior wall isolation to pulmonary vein isolation (PVI) was not better than PVI alone
11 Jan, 2023 | 14:33h | UTCEffect of Catheter Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial Wall Isolation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The CAPLA Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Catheter Ablation for Persistent Atrial Fibrillation – JAMA (free for a limited period)
See also: Visual abstract
Reviews | Antiarrhythmic drugs and anesthesia
11 Jan, 2023 | 14:06h | UTCAntiarrhythmic drugs and anaesthesia: part 1. mechanisms of cardiac arrhythmias – BJA Education
Antiarrhythmic drugs and anaesthesia. Part 2: pharmacotherapy – BJA Education
M-A | Techniques improving electrical cardioversion success for patients with atrial fibrillation
10 Jan, 2023 | 14:12h | UTC
The year in cardiovascular medicine 2022: the top 10 papers in arrhythmias
9 Jan, 2023 | 14:19h | UTCThe year in cardiovascular medicine 2022: the top 10 papers in arrhythmias – European Heart Journal
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Arrhythmias https://t.co/D3GM1l8TgW@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #CVD #arrhythmias pic.twitter.com/kxXqyEx8KM
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
The ‘10 commandments’ for the 2022 ESC Guidelines on ventricular arrhythmias and prevention of sudden cardiac death.
9 Dec, 2022 | 13:29h | UTCOriginal Guideline: #ESCCongress | 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.
M-A | Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
9 Dec, 2022 | 13:20h | UTC
Cohort Study | Poor R-wave progression as a predictor of sudden cardiac death in the general population and subjects with CAD.
8 Dec, 2022 | 12:58h | UTCCommentary: Poor R-wave progression is linked to sudden cardiac death: Study – Medical Dialogues
Commentary on Twitter
Poor R-wave progression as a predictor of sudden cardiac death in the general population and subjects with coronary artery disease – OPEN ACCESS! https://t.co/ScaZVvsbCU
— HeartRhythm (@hrs_journal) June 7, 2022
Podcast | Atrial fibrillation: rhythm control, catheter ablation, Afib in the hospital, and left atrial appendage closure.
6 Dec, 2022 | 13:42h | UTC
Monitoring and diagnosis of intermittent arrhythmias: evidence-based guidance and role of novel monitoring strategies.
30 Nov, 2022 | 13:34h | UTC
Review | Obesity as a risk factor for cardiac arrhythmias.
25 Nov, 2022 | 12:21h | UTCObesity as a risk factor for cardiac arrhythmias – BMJ Medicine
Commentary on Twitter
#Review: Obesity as a risk factor for cardiac #arrhythmias ▶️https://t.co/WR1jQd4swt#MedTwitter@DrKiranPatel1, @DrFuSiongNg pic.twitter.com/nZ6tPFTbKQ
— BMJMedicine (@BMJMedicine) November 14, 2022
RCT | Subcutaneous vs. transvenous implantable cardioverter defibrillator implantations.
22 Nov, 2022 | 13:19h | UTCPerioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations: A Randomized, Multicenter Trial – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentaries:
Subcutaneous ICD Reduces Lead-Related Complications – HealthDay
Related:
Subcutaneous or Transvenous Defibrillator Therapy – New England Journal of Medicine
Commentary on Twitter
New from @PHRIresearch @McMasterU: S-ICDs reduce lead-related complications by 92% w/out compromising effectiveness of shocks, but trend towards more inappropriate shocks: https://t.co/i7TtRr0PqP pic.twitter.com/Jhp7uprJT7
— Annals of Int Med (@AnnalsofIM) November 8, 2022
2ry analysis of a RCT | Device-related complications in subcutaneous versus transvenous ICD.
22 Nov, 2022 | 13:16h | UTCOriginal Study: Subcutaneous or Transvenous Defibrillator Therapy – New England Journal of Medicine
Related: Perioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations: A Randomized, Multicenter Trial – Annals of Internal Medicine (link to abstract – $ for full-text)
RCT | A small study tested Apixaban’s efficacy and safety versus a Vitamin K-antagonist in patients on chronic hemodialysis.
11 Nov, 2022 | 13:52h | UTCRelated Study: Apixaban for Patients with Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial – Circulation
AHA Scientific Statement | Arrhythmias in repaired Tetralogy of Fallot.
9 Nov, 2022 | 12:33h | UTCSummary: Arrhythmias in Repaired Tetralogy of Fallot – American Heart Association
Top Things to Know: Arrhythmias in Repaired Tetralogy of Fallot – American Heart Association
Commentary: Challenges in Managing Arrhythmias in Adult Tetralogy of Fallot – American Heart Association
RCT | In patients with paroxysmal, untreated AF, cryoballoon ablation reduced recurrence compared to drug therapy.
8 Nov, 2022 | 12:29h | UTCProgression of Atrial Fibrillation after Cryoablation or Drug Therapy – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
Initial treatment of paroxysmal atrial fibrillation with cryoballoon ablation was associated with a lower incidence of persistent atrial tachyarrhythmias over 3 years than rhythm-control medications. #AHA22 https://t.co/ZjLkt9L2xr pic.twitter.com/tzRiDPBSdx
— NEJM (@NEJM) November 7, 2022
Review | Oral anticoagulant use in patients with atrial fibrillation and chronic kidney disease.
8 Nov, 2022 | 12:02h | UTC
RCT | Effect of high-intensity interval training in patients with atrial fibrillation.
3 Nov, 2022 | 13:53h | UTC
Commentary from the author on Twitter (thread – click for more)
🎃Trick or treat (we hope the latter):
Our RCT exploring HIIT vs. MICT in patients with #afib is now online in @JAMANetworkOpen.
HIIT was not superior to MICT. Both effective & safe options to improve physical & mental health.
(1/4)
— Jennifer Reed (@DrJenniferReed) October 31, 2022
Under a CC-BY License License
Observational study suggests Apixaban for AF is associated with a lower risk of GI bleeding vs. other DOACs.
3 Nov, 2022 | 13:32h | UTCComparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation: A Multinational Population-Based Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)
News Release: Best blood thinner for minimizing bleeding risk identified – University College London
Commentary: GI Bleeding Lower With Apixaban Versus Other DOACs in A-Fib – HealthDay
M-A | The success rate of cardioversion for AF was similar between anterior-posterior vs. anterior-lateral electrodes position.
1 Nov, 2022 | 12:09h | UTC
RCT | Pulmonary vein isolation plus individualized substrate ablation of atrial low-voltage myocardium reduced A-fib recurrence.
28 Oct, 2022 | 13:24h | UTCLow-Voltage Myocardium-Guided Ablation Trial of Persistent Atrial Fibrillation – NEJM Evidence
Commentary on Twitter
Original Article: “Low-Voltage Myocardium-Guided Ablation Trial of Persistent Atrial Fibrillation,” by @YanHuo2022 et al. https://t.co/OYqzAt7ks0#CardioTwitter #AFib #MedTwitter @tudresden_de @ThomasGaspar16 @purerfellner @EPyoungstar @UKSH_KI_HL @MedUni_Wien @KardiologieWien pic.twitter.com/0ly3pjNiPa
— NEJM Evidence (@NEJMEvidence) October 24, 2022
Cohort Study | Cannabis, cocaine, methamphetamine, and opiates linked to increased risk of incident atrial fibrillation.
27 Oct, 2022 | 12:29h | UTCEditorial: Drug abuse and risk of atrial fibrillation: a neglected association – European Heart Journal
Commentaries:
Marijuana, Meth, Cocaine Use Can Help Trigger Dangerous A-Fib – HealthDay
Commentary on Twitter
New study just published in EHJ suggests that cannabis, cocaine, methamphetamine, and opiates may increase the risk of incident atrial fibrillation: discover more!https://t.co/ySrmaLnacC#AF #methamphetamine #cocaine #opiate #cannabis #cardiotwitter @escardio @ESC_Journals pic.twitter.com/YCvqjPGQjG
— EHJ Editor-in-Chief (@ehj_ed) October 20, 2022
Cohort Study | Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy.
24 Oct, 2022 | 14:08h | UTCEditorial: Arrhythmogenic cardiomyopathies in children: seek and you shall find – European Heart Journal
Commentary on Twitter
Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy: discover more in EHJ!https://t.co/kA60A1zjRt#ARVC #children #screening #heart #transplantation #cardiotwitter @escardio @ESC_Journals pic.twitter.com/fq4X8doBMI
— EHJ Editor-in-Chief (@ehj_ed) September 6, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ License